GEEN Biotechnology is an innovative company that specializes in developing enabling technologies for synthetic biology. Founded in 2015 in Istanbul, Turkey, with the support of The Republic of Turkey Ministry of Science, Industry, and Technology, GEEN has quickly become a leader in the field. They have major research and development operations in Istanbul, where they focus on groundbreaking genetic circuit technology.

GEEN's flagship product is GeenOS, the world's first artificial biological life form. This universal plasmid allows for the accurate running of complex genetic circuits. Additionally, GEEN offers a range of SynBio products, including homemade kits, plasmids, and other products available for purchase online.

In 2018, GEEN launched the Intellivir Program, which focuses on personalizing and enhancing Oncolytic Viruses as the first commercial application of GeenOS. They use advanced genetic circuits to train viruses for specific skills by evolving them inside animal models. In addition to their work with viruses, GEEN also develops industrial strains of bacteria, yeast, and plants using genome editing and directed evolution techniques.

With their cutting-edge technology and commitment to advancing synthetic biology, GEEN Biotechnology is at the forefront of the industry, revolutionizing the way we understand and manipulate living organisms